Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapyI Ray-Coquard, C Borg, Th Bachelot, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2001
Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine)hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modelingN Kim, A F El-Kattan, C S Asbill, et al.
Bulletin Du Cancer|January 1, 1990
[Developments in the treatment of osteosarcoma since 1979. Report of the statistics at the Centre Léon-Bérard]M Brunat-Mentigny, P Biron, R Kohler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'AdulteH Tilly, N Mounier, P Lederlin, et al.
Presse Medicale (Paris, France : 1983)|June 11, 1988
[Hemoperfusion on charcoal and hemodialysis in acute poisoning caused by methotrexate]D Frappaz, E Bouffet, P Cochat, et al.
Bulletin Du Cancer|February 1, 1993
Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysisH Sobol, S Mazoyer, S A Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2006
Sarcomas and malignant phyllodes tumours of the breast--a retrospective studyC Confavreux, A Lurkin, N Mitton, et al.
Bone Marrow Transplantation|November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancerP Biron, M Durand, H Roché, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study GroupI Ray-Coquard, A Le Cesne, M T Rubio, et al.
Pageof 16